logo
  • Home
  • People, Patients, Loved Ones
    • NHF Blog
    • HeadWise™ Podcast
    • Complete Headache Chart
    • Living With Migraine™
    • Migraine University©
    • Patient Assistance Programs
    • Disability Benefits
    • Clinical Trials
    • Publications
    • Webinars
    • NHF On the Job™
  • Military Community
  • Find a Provider
  • Donate
  • Healthcare Practitioners & Researchers
    • AQH Certification
    • Research
    • Primary Care Migraine™
  • Action4Access™
  • Home
  • People, Patients, Loved Ones
    • NHF Blog
    • HeadWise™ Podcast
    • Complete Headache Chart
    • Living With Migraine™
    • Migraine University©
    • Patient Assistance Programs
    • Disability Benefits
    • Clinical Trials
    • Publications
    • Webinars
    • NHF On the Job™
  • Military Community
  • Find a Provider
  • Donate
  • Healthcare Practitioners & Researchers
    • AQH Certification
    • Research
    • Primary Care Migraine™
  • Action4Access™

Topiramate vs Erenumab

January 2022, Episode 110: The HER-MES trial is a newly published study comparing the tolerability and efficacy of topiramate (Topamax) and erenumab (Aimovig). The results of this trial could impact prescribing practices and payor policies. Tune in this afternoon for…

Read More

National Headache Foundation Logo

The National Headache Foundation is a 501(c)(3) tax exempt organization.

Learn More

  • NHF Blog
  • About
  • Contact Us
  • Media Inquiry
  • Donate

Contact Us

162 W. Hubbard Street, Suite 500
Chicago, Illinois 60654

Phone: 312.274.2650
Toll-Free: 888-NHF-5552 (888-643-5552)
Email: [email protected]

HeadWise Podcast

© 2025 National Headache Foundation. All Rights Reserved. Website by CyberOptik

Star Rating Badge Full Color
candid seal platinum 2025
  • Financials
  • Terms
  • Privacy Policy
  • Disclaimer